The Discounted Cash Flow (DCF) valuation of ANI Pharmaceuticals Inc (ANIP) is 81.06 USD. With the latest stock price at 63.25 USD, the upside of ANI Pharmaceuticals Inc based on DCF is 28.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.9% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 47.36 - 262.93 | 81.06 |
| Upside | -25.1% - 315.7% | 28.2% |